Skip to Content

Coronavirus information for Feinberg.

Commentary: GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response

Analytics

17 views and 1 downloads since May 5, 2022